Faron Appoints Marie-Louise Fjällskog as CMO |
January 03, 2022 | January 2022 Bond Updates |
TURKU, Finland and BOSTON, Jan. 3, 2022 /PRNewswire/ -- Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, is... |
View more at: https://www.prnewswire.com:443/news-releases/faron-appoints-marie-louise-fjallskog-as-cmo-301452589.html |
Related News |